Preview

Артериальная гипертензия

Расширенный поиск

Результаты исследования ADVANCE - движение вперед в лечении артериальной гипертонии и сахарного диабета

https://doi.org/10.18705/1607-419X-2008-14-3-288-293

Полный текст:

Об авторе

Ю. Карпов
ФГУ РКНПК Росмедтехнологий
Россия


Список литературы

1. dler A., Stratton I.M., Neil H., et al. Association of systolic blood pressure with macrovascular and micro vascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-419.

2.

3. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-1187.

4.

5. The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 88-136.

6.

7. Stratton I.M., Adler A.L., Neil H.A. et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.

8.

9. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.

10.

11. The ADVANCE Collaborative Group: Rationale and design of the ADVANCE Study: a randomised trial of blood pressure lowering and intensive glucose control in high risk individuals with Type 2 diabetes mellitus. J Hypertens 2001; 19: 21-28.

12.

13. ADVANCE Collaborative Group/ ADVANCE - Action in diabetes and vascular disease: patient recruitment and characteristics of the study population at baseline. Diabet./ Med./ 2005; 1-7.

14.

15. ADVANCE Collaborative Group. Effects of fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 828-840.

16.

17. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572.

18.

19. Yeon SS, Nesto RW. Implications of intensive glycemic control on cardiovascular disease: early reports from the ACCORD and ADVANCE Trials. Rev Cardiovasc Med 2008;9(1):l-4.

20.

21. Cefalu WT, Watson K. Intensive glycemic control and cardiovascular disease. Observations from the ACCORD study. Diabetes 2008; 57: 1163-1165.

22.

23. Goede P, Lund-Andersen H, Parving HH, et al. Effect of multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-589.

24.

25. Holman RR, Paul SJ, Bethel MA, et al. Ten-year follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; [ Epub ahead of print].

26.

27. Chalmers J. ADVANCE: new results. EASD 2008 Meeting, September 8. Oral presentation.

28.


Для цитирования:


Карпов Ю. Результаты исследования ADVANCE - движение вперед в лечении артериальной гипертонии и сахарного диабета . Артериальная гипертензия. 2008;14(3):288-293. https://doi.org/10.18705/1607-419X-2008-14-3-288-293

For citation:


Karpov Y. Results of ADVAVCE study - an advance in the treatment of hypertension and diabetes mellitus . "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2008;14(3):288-293. (In Russ.) https://doi.org/10.18705/1607-419X-2008-14-3-288-293

Просмотров: 109


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)